Leukobiopsy – A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations
Detection of unique oncogenic alterations encoded by the sequence or biochemical modification in cancer-associated transforming macromolecules has revolutionized diagnosis, classification and management of human cancers. While these signatures were traditionally regarded as largely intracellular and...
Main Authors: | Shilpa Chennakrishnaiah, Thupten Tsering, Saro Aprikian, Janusz Rak |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01608/full |
Similar Items
-
Extracellular vesicles – biomarkers and effectors of the cellular interactome in cancer
by: Janusz eRak
Published: (2013-03-01) -
Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis
by: Vitor H. Almeida, et al.
Published: (2019-07-01) -
Extracellular Vesicles and the Promise of Continuous Liquid Biopsies
by: Don Armstrong, et al.
Published: (2018-01-01) -
MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods
by: Rares Drula, et al.
Published: (2020-07-01) -
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
by: Etienne Buscail, et al.
Published: (2019-06-01)